Technical Analysis of Arsenic and Mercury Detection Methods for Chinese Herbal Medicines

Arsenic and mercury are among the most strictly regulated toxic elemental impurities in Chinese herbal medicines, and their accurate quantification is essential for pharmacopoeia compliance, patient safety, and international market access. This technical analysis reviews the sources of contamination, applicable regulatory limits, and the principal analytical platforms—from hydride generation atomic fluorescence spectrometry to ICP-MS—used to determine total arsenic and total mercury in herbal materials, extracts, and finished products.

Technical Overview

Chinese herbal medicines (CHM), including botanical crude drugs, decoction pieces, extracts, and classical formulas, can accumulate toxic elements from multiple environmental and anthropogenic sources. Arsenic and mercury are the two elements of greatest toxicological concern because both accumulate in medicinal plant roots, rhizomes, and bark tissues, and both exhibit severe chronic toxicity even at low exposure levels. Inorganic arsenic compounds are classified as Group 1 human carcinogens by the International Agency for Research on Cancer, while mercury—particularly methylmercury and inorganic divalent mercury—is a potent neurotoxin and nephrotoxin.

Contamination pathways include uptake from naturally mineralized or industrially polluted soils, irrigation water, atmospheric deposition from coal combustion and smelting, pesticide and fertilizer residues, and improper processing or storage practices. Because herbal matrices are complex organic systems with high cellulose, starch, pigment, and essential-oil content, the analytical challenge lies not only in achieving low detection limits but also in achieving complete matrix destruction and quantitative recovery of both volatile mercury and chemically bound arsenic species.

Regulatory frameworks worldwide have established firm concentration limits. The Chinese Pharmacopoeia (2020 edition) specifies, for medicinal materials and decoction pieces, maximum limits of 2 mg/kg for arsenic and 0.2 mg/kg for mercury. Comparable control strategies appear in USP General Chapters on elemental impurities for dietary supplements and drug products, and in European and WHO guidance documents. Reliable detection technology is therefore a cornerstone of quality control for any herbal manufacturer, importer, or testing laboratory.

Testing Samples

Crude Herbal Materials and Decoction Pieces

Raw botanical materials—roots, rhizomes, stems, leaves, flowers, fruits, seeds, and barks—represent the largest sample category. Roots and rhizomes (such as licorice, astragalus, and angelica species) generally carry the highest heavy metal burden due to direct soil contact. Decoction pieces are processed slices that have undergone washing, cutting, steaming, stir-frying, or honey-frying, and their processing history must be documented because certain treatments can concentrate or partially remove elemental residues.

Extracts, Powders, and Finished Dosage Forms

Concentrated extracts, spray-dried or freeze-dried powders, granules, tablets, capsules, pills, oral liquids, and tinctures constitute the second major category. These finished products typically show concentration factors of three- to ten-fold relative to the starting herb, so limits must be recalculated based on the daily dose and the herb-to-extract ratio. Liquid and semi-solid matrices require special digestion strategies to control foaming and exothermic reactions.

Mineral-Derived Medicines and Special Matrices

Mineral Chinese medicines such as cinnabar (mercury sulfide) and realgar (arsenic sulfide) intentionally contain enormous quantities of mercury and arsenic. For these materials, the analytical objective shifts from trace screening to precise assay of total content and, critically, quantification of bioavailable free (soluble) mercury and arsenic species, since the sulfide-bound forms are far less toxic than soluble inorganic species. Fecal- and animal-derived medicines, as well as herbal formulas containing mineral adjuvants, are treated as special matrices requiring validated method adaptations.

• Sample intake for routine testing is typically 0.2–0.5 g of homogenized, milled (passing a 60–80 mesh sieve) material.
• Representative sampling plans follow pharmacopoeial sampling protocols to account for heterogeneity between and within batches.
• Moisture content is determined in parallel so that results can be reported on a dry-weight basis when required.

Testing Items

Core testing items for herbal quality control cover both total elemental content and, where applicable, chemical speciation:

• Total arsenic (sum of all arsenic species), with a routine limit of 2 mg/kg in crude drugs and decoction pieces under the Chinese Pharmacopoeia.
• Total mercury (sum of all mercury species), with a routine limit of 0.2 mg/kg in crude drugs and decoction pieces.
• Speciated arsenic: inorganic As(III) and As(V), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), since toxicity is dominated by the inorganic fraction.
• Speciated mercury: inorganic Hg(II) versus methylmercury, relevant for marine-derived and certain processed materials.
• Auxiliary heavy metals frequently measured in the same run: lead, cadmium, and copper, to complete the five-element pharmacopoeial panel.
• Soluble (bioaccessible) arsenic and mercury fractions for mineral medicines, determined by simulated gastric or intestinal extraction.

Testing Methods

Sample Preparation and Digestion

Complete destruction of the organic matrix with quantitative analyte retention is the critical first step. Closed-vessel microwave digestion with concentrated nitric acid, often with a small addition of hydrogen peroxide, is the reference technique because it prevents the severe volatilization losses of elemental mercury and volatile arsenic chlorides that plague open wet digestion and dry ashing. Typical programs ramp to 180–200 degrees Celsius over 20–30 minutes and hold for 20–40 minutes. Boric acid may be added after digestion when hydrofluoric acid is used for siliceous matrices. Every batch must include reagent blanks, duplicate samples, spiked recovery samples, and a certified herbal reference material to demonstrate method control.

Hydride Generation Atomic Fluorescence Spectrometry (HG-AFS)

HG-AFS is the workhorse technique in Chinese herbal testing laboratories because it combines exceptional sensitivity for hydride-forming elements with low instrument and operating costs. Arsenic is reduced to arsine (AsH3) by sodium borohydride in an acidic carrier, swept into an argon-hydrogen flame, and quantified by atomic fluorescence; detection limits of 0.01–0.05 micrograms per liter are routinely achieved. For mercury, cold vapor generation (reduction of Hg(II) to atomic mercury vapor) coupled to AFS provides detection limits below 0.01 micrograms per liter. Pre-reduction of pentavalent arsenic to the trivalent state with potassium iodide and ascorbic acid, or with thiourea, is required before hydride generation to measure total arsenic. Matrix interference is minimal because the hydride generation step physically separates the analyte from the bulk digested matrix.

Atomic Absorption Spectrometry (AAS)

• Graphite furnace AAS (GFAAS): suitable for arsenic with palladium-magnesium matrix modification, achieving characteristic masses in the picogram range, though arsenic determination is hampered by spectral and chemical interferences requiring background correction.
• Hydride generation AAS (HG-AAS): a classical approach for arsenic with detection limits near 0.1–0.5 micrograms per liter; widely used in laboratories with basic AAS instrumentation.
• Cold vapor AAS (CV-AAS): the traditional reference method for mercury, relying on tin(II) chloride or borohydride reduction and gas-liquid separation, with detection limits around 0.02–0.1 micrograms per liter.

Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES)

ICP-OES offers simultaneous multi-element capability (arsenic, mercury, lead, cadmium, copper in one run) with detection limits in the 1–10 microgram per liter range. It is adequate for compliance screening against milligram-per-kilogram limits, but its sensitivity for arsenic (188.979 nm or 193.696 nm lines) and mercury (184.950 nm line in vacuum UV or 253.652 nm) is generally inferior to AFS and ICP-MS, so it is best positioned as a high-throughput screening tool rather than a definitive trace-level method.

Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

ICP-MS is the most powerful and increasingly dominant platform for elemental impurity control in herbal medicines. It delivers simultaneous quantification of the full pharmacopoeial element panel with detection limits at or below 0.01 micrograms per liter for arsenic and mercury, isotopic confirmation capability, and wide linear dynamic range spanning trace and elevated levels in a single run. Key technical considerations include:

• Removal of the argon chloride polyatomic interference on arsenic-75 using helium kinetic energy discrimination or hydrogen/cell reaction gases, essential when nitric-hydrochloric acid digests are used.
• Control of mercury memory effects through gold (approximately 200 micrograms per liter) stabilization in rinse solutions and extended washout protocols.
• Internal standardization, typically with indium, iridium, rhodium, or bismuth, to correct for matrix suppression and drift.
• Use of collision-cell tuning and interference checks validated with certified reference materials such as NIST SRM 1573a (tomato leaves) or GBW herbal matrix standards.

Speciation Analysis by HPLC-ICP-MS

Because toxicity and regulatory risk are driven by chemical form rather than total content, hyphenated speciation methods are increasingly applied. Anion-exchange HPLC with ammonium carbonate or phosphate mobile phases coupled online to ICP-MS separates As(III), As(V), MMA, and DMA within 10–15 minutes; cation-exchange or reversed-phase conditions resolve methylmercury from inorganic mercury. Speciation data allow laboratories and regulators to distinguish genuinely hazardous inorganic arsenic from largely innocuous organoarsenicals such as arsenosugars, preventing false failures of compliant herbal products.

Method Selection and Validation

Method choice balances sensitivity requirements, throughput, budget, and regulatory expectations. AFS-based methods offer the best cost-to-sensitivity ratio for the dedicated arsenic-mercury pair and align with Chinese Pharmacopoeia procedures; ICP-MS is preferred when the full element panel, lowest detection limits, or international data packages (USP, ICH Q3D-style reporting) are required. All methods must be validated for specificity, linearity (typically r greater than 0.999 across the working range), accuracy (spiked recoveries of 80–120 percent), precision (RSD below 5 percent), limits of detection and quantification, ruggedness, and measurement uncertainty before being used for batch release decisions.

Applications

Arsenic and mercury detection technology supports a broad spectrum of practical activities across the herbal medicine industry:

• Incoming inspection of crude drugs at GMP manufacturing sites and at traditional Chinese medicine hospitals and pharmacies.
• Batch release testing of extracts, granules, tablets, and other finished products against pharmacopoeial limits.
• Export certification and registration dossiers for markets governed by the Chinese Pharmacopoeia, USP, EP, and national food-drug regulations.
• Good Agricultural Practice (GAP) cultivation site evaluation, soil and irrigation water monitoring, and contamination source tracing.
• Processing research, for example evaluating whether washing, peeling, soaking, boiling, or stir-frying reduces arsenic and mercury levels in decoction pieces.
• Safety evaluation of mineral medicines such as cinnabar and realgar, including soluble-species assays and dose-based exposure assessment.
• Stability studies, storage-container compatibility testing, and post-market surveillance or adverse-event investigations.

FAQ

Why are arsenic and mercury specifically prioritized in herbal medicine testing?

Arsenic and mercury combine high chronic toxicity, confirmed carcinogenic or neurotoxic potential, environmental ubiquity, and significant accumulation in the root and rhizome materials that dominate the Chinese materia medica. They are also chemically tricky analytes—mercury is volatile and prone to loss during preparation, while arsenic speciation strongly affects toxicological interpretation—which is why regulators single them out for dedicated, validated procedures rather than general heavy-metal screening alone.

What detection limits must a laboratory achieve?

To demonstrate compliance with a 0.2 mg/kg mercury limit and a 2 mg/kg arsenic limit with adequate margin, the method limit of quantification should be no higher than approximately 0.02–0.05 mg/kg for mercury and 0.1–0.2 mg/kg for arsenic. HG-AFS and ICP-MS both comfortably meet these requirements; laboratories should report both the result and the method LOQ so clients can judge the safety margin.

How are mineral medicines containing cinnabar or realgar evaluated?

For these materials, total arsenic or mercury content is an identity and assay parameter rather than a contamination limit. Testing focuses on quantifying total content precisely, then measuring the soluble or bioavailable fraction through simulated gastrointestinal extraction and speciation analysis, because the sulfide mineral forms are markedly less bioavailable than soluble inorganic species. These products are typically dosed strictly and evaluated through exposure assessment against tolerable intake values.

What sample quantity and turnaround time are typical?

Most laboratories request 20–50 g of milled sample for a full elemental panel, allowing for moisture determination, duplicate digestion, and any required retesting. Standard turnaround is 5–10 working days for routine total arsenic and mercury determination; speciation analysis by HPLC-ICP-MS may require 10–15 working days due to method setup and confirmation.

Which technique is the best choice overall?

For laboratories focused on the Chinese Pharmacopoeia five-element panel with cost efficiency, HG-AFS paired with ICP-OES or AAS for the remaining elements is fully adequate. For laboratories serving international registrations, requiring the lowest detection limits, or needing speciation capability, ICP-MS—with collision-cell interference removal and mercury memory management—is the recommended platform. Many high-volume operations combine both: ICP-MS as the primary release method and AFS as a confirmatory or backup technique.

Can total arsenic results be misleading?

Yes. Some marine-influenced or freshwater-collected herbal materials contain elevated organoarsenicals with negligible toxicity, which can cause a total-arsenic failure that does not reflect actual risk. In such cases, HPLC-ICP-MS speciation distinguishing inorganic As(III) and As(V) from MMA and DMA provides the scientifically defensible basis for safety assessment and regulatory dialogue.